Front
Page
Previous
Story
Next
Story |
![NIH Record vertical blue bar column separator](https://webarchive.library.unt.edu/eot2008/20090131093936im_/http://nihrecord.od.nih.gov/newsletters/bar.jpg) |
CSR Adds Five SRAs to
Staff
Dr.
Lawrence Baizer is the new scientific review
administrator for the neurogenesis and cell fate study
section at the Center for Scientific Review. He earned
his Ph.D. in pharmacology from the University of Colorado
Health Sciences Center. After postdoctoral work in molecular
neurobiology at Massachusetts General Hospital, Baizer
moved to the Neurological Sciences Institute of the Oregon
Health Sciences University, where he was a principal investigator
from 1989 to 2000. His laboratory investigated the molecular
mechanisms of action of growth-associated protein (GAP)-43,
a protein involved in axonal growth during neuronal development
and regeneration. For the past 3 years, Baizer was a senior
scientist at Bioject, Inc., where he explored new applications
for the company's technology and was involved in several
clinical vaccine trials.
Dr.
Valerie Durrant recently joined the Center
for Scientific Review as a scientific review administrator
with the health of the population integrated review group.
She will coordinate two of its special emphasis panels:
one that will review all of the IRG's small business grant
applications and another that will review non-R01 grant
applications in the area of social sciences and population
studies. Before coming to CSR, Durrant was a program officer
for the Committee on Population at the National Academies
of Science, where she directed studies on population issues
in developing countries, including studies on transitions
from childhood to adulthood, leveraging longitudinal data,
and the economic benefits of investing in youth. Durrant
holds a Ph.D. in sociology with an emphasis in demography
from the University of Maryland. After earning her Ph.D.,
she was a Berelson postdoctoral fellow at the Population
Council, conducting research on adolescents and on the
influence of the status of women on infant and child mortality
and children's schooling in Pakistan.
Dr.
Richard Kostriken has
joined the Center for Scientific Review as the scientific
review administrator of the SSS-Z study section, which
reviews small business and other grant applications involving
the detection, characterization, and inactivation of viruses
and parasites. He earned his Ph.D. from State University
of New York at Stony Brook, where he studied the genetics
and biochemistry of genomic rearrangements in bacteria
and yeast. His postdoctoral work focused on understanding
the genetic regulation of embryonic development in invertebrate
organisms. As a faculty member at New York Medical College,
he conducted NIH-funded research into the genetic regulation
of chromosome structure. Before coming to CSR, he worked
as a senior scientist at Biolog Inc., in Hayward, Calif.
Dr.
Jerome Wujek recently joined the Center for
Scientific Review as a scientific review administrator,
coordinating the review of small business research grant
applications related to vision research for the brain
disorders and clinical neuroscience integrated review
group. He earned his Ph.D. from the department of anatomy
at Case Western Reserve University. His work there focused
on the role of axonal transport in regulating axonal regeneration.
In subsequent postdoctoral positions at the University
of Maryland and Cincinnati Children's Hospital, he investigated
the relationship of astrocytes to axonal regeneration
in spinal cord injury. At Gliatech, Inc., a start-up biotech
company in Cleveland, he was part of a research and development
team working on therapies for surgical adhesions and for
Alzheimer's disease. He comes to CSR from the department
of neurosciences of the Cleveland Clinic Foundation. As
a staff scientist there, he studied the role of microglia,
inflammation and axonal pathology in multiple sclerosis.
Dr.
Ai-Ping Zou has joined the Center for Scientific
Review as scientific review administrator for the hypertension
and microcirculation study section, a new panel that reviews
grant applications involving basic and applied aspects
of blood pressure regulation and microcirculation control.
He completed training as a physician at Tongji Medical
University in China and received his Ph.D. in physiology
at Heidelberg University in Germany. He previously served
as associate dean for academic affairs at TMU and was
an associate professor at the Medical College of Wisconsin.
Before coming to CSR, he was an NIH grantee, studying
transcriptional mechanisms mediating renal regulation
of arterial blood pressure and homocysteine-induced end-stage
renal damage associated with hypertension.
Up to Top |